REPLIGEN CORP - COMMON STOCK (RGEN)

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
56,222,082
Total 13F shares
47,109,897
Share change
-870,203
Total reported value
$12,469,909,891
Put/Call ratio
119%
Price per share
$264.84
Number of holders
488
Value change
-$237,031,385
Number of buys
201
Number of sells
232

Institutional Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q4 2021

As of 31 Dec 2021, REPLIGEN CORP - COMMON STOCK (RGEN) was held by 488 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 47,109,897 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, Invesco Ltd., WCM INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, FRED ALGER MANAGEMENT, LLC, AMERIPRISE FINANCIAL INC, FRANKLIN RESOURCES INC, and ALLIANCEBERNSTEIN L.P.. This page lists 488 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.